Sarepta Therapeutics Inc. (SRPT) gapped open sharply higher Thursday and climbed in early trade, before settling into a range. Shares finished up by 1.80 at $14.40 on above average volume.
Sarepta Therapeutics has been gaining ground for the past 3 weeks and set a new high for the year. Thursday's surge in stock price was attributed to a television report which stated that the company's Eteplirsen drug for muscle weakness and loss of muscle tissue has shown positive signs in one patient.
For comments and feedback: editorial@rttnews.com